文献速递心血管胸部CT

心脏计算机断层扫描测量三尖瓣解剖反流口面积:新的预后见解

Tricuspid Anatomic Regurgitant Orifice Area by Cardiac Computed Tomography: Novel Outcome Insights.
PubMed 文献 · JACC Cardiovasc Imaging · 2025-10-28

本研究在4个Allina Health中心纳入174例临床显著三尖瓣反流患者,用4D-CTA测量解剖反流口面积(AROA)。中位随访2.3年,AROA≥1.1 cm²与医疗管理下全因死亡率独立相关(校正HR 2.23,95%CI 1.02-4.85,P=0.040),3年生存率68% vs 36%(P=0.013)。作者认为AROA测量应被考虑用于4D-CTA评估的三尖瓣反流患者。

要点

  • 4D-CTA可测量三尖瓣解剖反流口面积(AROA),AROA≥1.1 cm²提示医疗管理下死亡风险增高。
  • AROA≥1.1 cm²组三尖瓣环径、最大对合间隙、右室和右房容积更大,右室游离壁纵向应变更低。
  • AROA≥1.1 cm²与超额死亡独立相关(校正HR 2.23,95%CI 1.02-4.85,P=0.040)。

核心结论

  • 在临床显著三尖瓣反流患者中,4D-CTA测量的较高AROA与更差的右心重构强烈相关,并与超额死亡独立相关;4D-CTA除解剖评估外可提供预后相关的三尖瓣反流严重度评估,AROA测量应被考虑用于4D-CTA评估的三尖瓣反流患者。

研究设计与样本

  • 研究类型为预后研究(原文称首个结局研究),纳入2019至2023年在4个Allina Health中心评估三尖瓣介入的临床显著三尖瓣反流患者,共174例获得AROA测量;采用4D-CTA测量AROA,收集临床和超声心动图数据,感兴趣结局为诊断后医疗管理下的全因死亡。

关键影像表现/征象

  • AROA≥1.1 cm²组较AROA<1.1 cm²组三尖瓣环径更大、三尖瓣最大对合间隙更大、右室和右房容积更大(均P<0.001)。
  • AROA≥1.1 cm²组与AROA<1.1 cm²组右室射血分数相似,但前者右室游离壁纵向应变更低(P<0.001),提示右室功能更差。

诊断标准与关键数值

  • 样条曲线分析显示AROA 1.1 cm²为队列内与死亡率增高相关的阈值。
  • AROA≥1.1 cm²与超额死亡独立相关:校正HR 2.23(95%CI 1.02-4.85),P=0.040。
  • 医疗管理下3年生存率:AROA≥1.1 cm²组36%(Q1-Q3:28%-52%)vs AROA<1.1 cm²组68%(Q1-Q3:56%-82%),P=0.013。
  • AROA测量值中位数0.74 cm²(Q1-Q3:0.55-1.42 cm²)。

临床应用与阅片要点

  • 对4D-CTA评估的三尖瓣反流患者,作者认为应被考虑测量AROA以补充解剖评估并提供预后相关信息。
  • AROA≥1.1 cm²可提示更差的右心重构和医疗管理下超额死亡风险,可结合三尖瓣环径、对合间隙、右室和右房容积及右室游离壁纵向应变综合解读。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Anatomic regurgitant orifice area (AROA) can be measured by 4-dimensional (4D)-computed tomography angiography (CTA) to define tricuspid regurgitation (TR) severity, but its association with outcomes has not been established.

OBJECTIVES: This study aims to assess the independent prognostic value of TR quantification by 4D-CTA AROA measurement.

METHODS: Comprehensive clinical, echocardiographic and 4D-CTA data were collected from patients with clinically significant TR evaluated at 4 Allina Health centers between 2019 and 2023 for TR intervention. The outcome of interest was all-cause mortality under medical management after diagnosis.

RESULTS: AROA measurement was obtained in 174 patients (median age 83 years [Q1-Q3: 77- 97 years], left ventricular ejection fraction 58% [Q1-Q3: 51%-60%], right ventricular [RV] ejection fraction 46% [Q1-Q3: 41%-51%] and tricuspid AROA 0.74 cm2 [Q1-Q3: 0.55-1.42 cm2]). During a median follow-up of 2.3 years [Q1-Q3: 1.1-3.2 years], 49 (28%) patients died under medical management with 3-year survival rate of 55% [Q1-Q3: 45%-67%]. Spline curve analysis showed that AROA 1.1 cm2 was the threshold associated with increased mortality within the cohort. Patients with AROA ≥1.1 cm2 had higher TRI-SCOREs, larger tricuspid annulus dimension, tricuspid maximum coaptation gap, RV and right atrial volumes (all P < 0.001). Despite similar RV ejection fraction, patients with AROA ≥1.1 cm2 had worse RV function denoted by lower RV free-wall longitudinal strain (P < 0.001) compared to those with AROA <1.1 cm2. In multivariable analysis, AROA ≥1.1 cm2 remained independently associated with excess mortality (adjusted HR 2.23 [95% CI: 1.02-4.85]; P = 0.040) and worse 3-year survival under medical management (68% [Q1-Q3: 56%-82%] vs 36% [Q1-Q3: 28%-52%]; P = 0.013).

CONCLUSIONS: This first outcome study of patients with clinically significant TR examined by 4D-CTA shows that higher AROA measurement strongly associates with worse right heart remodeling and independently associates with excess mortality. Therefore, 4D-CTA, beyond anatomical assessment, provides prognostically relevant assessment of TR severity. Thus, AROA measurement should be considered in patients with TR evaluated by 4D-CTA.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Margonato D, Lopes BB, Hashimoto G, et al. Tricuspid Anatomic Regurgitant Orifice Area by Cardiac Computed Tomography: Novel Outcome Insights. JACC Cardiovasc Imaging. 2025. PMID: 41148069. doi:10.1016/j.jcmg.2025.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。